molecules of the month

LMB763 (nidufexor)

selective FXR partial agonist

orally efficacious in NASH models

from two 3M compound HTS and LBD

J. Med. Chem., Jan. 15, 2020

Novartis (GNF), San Diego, CA

LMB763 (nidufexor)
1 min read

LMB763 (nidufexor) (Novartis (GNF) oral in vivo selective FXR partial agonist)

request a trial

You don’t have time to read everything, but you can’t afford to fall behind.

Drug Hunter Premium is drug discovery, distilled, so you can quickly catch up and make informed decisions based on industry examples.

Get ahead now by requesting a trial.

already a member? log in: